Vir Biotechnology Stock Plunges on Flu Trial Failure
It was one of the hot stocks of the early pandemic era, its shares climbing more than 500% between the start of 2020 and the biotechnology sector’s peak in...
Stay updated with breaking news from Ivir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It was one of the hot stocks of the early pandemic era, its shares climbing more than 500% between the start of 2020 and the biotechnology sector’s peak in...
By Colin Kellaher Vir Biotechnology on Thursday said a Phase 2 study of its VIR-2482 candidate for the prevention of symptomatic influenza A illness missed...
By Colin Kellaher Vir Biotechnology shares slid more than 40% and hit a new multi-year low Thursday after the immunology company reported the failure of a...
It was one of the hot stocks of the early pandemic era, its shares climbing more than 500% between the start of 2020 and the biotechnology sector’s peak in...
Around 200 representatives will gather at a health conference on July 20 to discuss innovative approaches to pharma-healthcare development.